Montell Jordan is giving a less-than-ideal update on his health journey. During a recent appearance on “Today,” the 56-year-old R&B singer revealed that nearly a year after undergoing a radical ...
Tribune Content Agency on MSN
The Medicine Cabinet: Ask the Harvard Experts: The journey of active surveillance for ...
Q: I have low-grade prostate cancer and have chosen active surveillance. What can I expect and what might change this approach? A: Active surveillance (AS) is now a very common choice for men with low ...
For decades, men with the disease faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane ...
The PSA test is often paired with a digital rectal exam (DRE), where a doctor inserts their finger into the rectum to feel the prostate gland. “We look for any bumps or lumps or any signs of ...
7 天on MSN
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
Montell Jordan says that his cancer has returned after he had his prostate removed last year. The “This Is How We Do It” singer revealed on the Today show on Sept. 3 that follow-up scans have detected ...
Hunter Mulholland is a Newsweek contributor based in St. Louis, Missouri. His focus is MLB Content. Hunter has been with Newsweek since April 2025 and previously worked at Fansided and STL Sports ...
Apple’s annual iPhone event kicks off later today, and we may finally see the iPhone Air. That would appear alongside the usual iPhone refresh, with an array of iPhone 17 devices. We’re expecting four ...
As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...
News-Medical.Net on MSN
Gene expression test identifies prostate cancer patients who benefit from hormone therapy
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
An eminent oncologist, cancer researcher, and cancer center director is promoting a study that seems to show—but, when ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果